Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOX

Uric acid vs progression-free survival (PFS) in colorectal cancer — High baseline SUA linked to poor PFS in non-metastatic CRC using FOLFOX (HR=2.59; p=0.018) & in male patients using FOLFIRI (HR=3.77; p=0.012) — High SUE... thus promotes tumor progres

New research: Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOX: Background High serum uric acid… https://t.c